CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-08 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +365,265 | 365,265 | ||
| 2016-01-08 | LEVIN ALAN G Director | Grant or award | +248,032 | 248,032 | ||
| 2016-01-08 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +276,140 | 276,140 | ||
| 2016-01-08 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +365,265 | 365,265 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award | +3,725,711 | 3,725,711 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +226,486 | 226,486 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +91,316 | 91,316 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +91,316 | 91,316 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +109,579 | 109,579 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +365,265 | 365,265 | ||
| 2016-01-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +219,159 | 219,159 | ||
| 2014-08-04 | Weinberg Mark A. Sr. V.P.- Clinical Development | Grant or award · Stock Option (right to buy) | +521,475 | 521,475 | ||
| 2014-07-24 | STACKS NELSON K. Director | Grant or award · Stock Option (right to buy) | +61,374 | 61,374 | ||
| 2014-07-24 | SIMES STEPHEN M Chief Executive Officer | Grant or award · Stock Option (right to buy) | +542,975 | 542,975 | ||
| 2014-07-24 | SHERRIS DAVID Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +119,482 | 119,482 |
Page 14 of 17 · 321 trades